Company Profile

iCarTab Biotechnology was established in 2015, focusing on the preclinical research of antibody drugs and cell drugs, providing professional CROs such as drug discovery, pharmaceutical research and preclinical research for global new drug research and development companies and basic life science research institutions service. The company has a number of independent research and development leading commercial technologies, and has built a nano antibody research and development platform, a fully human antibody screening platform, a mouse monoclonal antibody platform, a genetic engineering cell line construction platform, a phage display platform, etc., respectively in Suzhou, Ningbo, Malaysia It has a research and development, production base and alpaca breeding base.

The core members of the company's R&D team have profound academic backgrounds and rich practical experience, and are proficient in cross-disciplinary and multidisciplinary technologies such as antibody engineering, immunology, virology, molecular biology, and clinical medicine. They have been used by nearly a thousand large-scale pharmaceutical companies and biomedical research institutions at home and abroad. Provides reliable, comprehensive and efficient pre-clinical services for new drug research and development. In addition, the company has been cooperating with many domestic and foreign tumor immunologists with rich clinical experience and many clinical experiment transformation bases throughout the year, and has professional and standardized clinical transformation experience and rapid verification channels. Love Kant organisms in the customer first, pragmatic innovation, quality priority purposes, to provide customers with fast and efficient drug research and development of innovative solutions.

Next: Contact Us